Junshi Biosciences (01877): Tuoyi New Indication Included in National Medical Insurance Catalog

date
16/11/2026
Zhitong Finance APP News, Junshi Biosciences (01877) announced that recently, the indication of the Company's product toripalimab injection (trade name: Tuoyi, product code: JS001) in combination with disitamab vedotin for HER2-expressing locally advanced or metastatic urothelial carcinoma was successfully included in the Class B scope of the "National Drug Catalog for Basic Medical Insurance, Work-Related Injury Insurance, and Maternity Insurance (2026)" (hereinafter referred to as the "National Medical Insurance Catalog"). The new version of the National Medical Insurance Catalog will be officially implemented starting January 1, 2027.